Safety of Nitroglycerin for Field Treatment of STEMI
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Nichole Bosson, MD, MPH
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Ucla Ronald Reagan Medical Center
Los Angeles, California, United States
- Harbor-Ucla Medical Center
Torrance, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 31 Dec 2016
- Completion
- 30 Apr 2017
- Last update posted
- 25 Aug 2017
- Registered enrollment
- 940
- Registry id
- NCT02407002
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.